台股 » 個股 » 和康生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

和康生

(1783)
可現股當沖
  • 股價
    43.40
  • 漲跌
    ▲0.40
  • 漲幅
    +0.93%
  • 成交量
    90
  • 產業
    上市 生技醫療類股
  • 126人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
和康生 (1783)籌碼相關-元富-同大 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw04/0104/2005/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0402/1602/2603/1003/204042.54547.55052.55557.5May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

元富-同大 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/01043.4500.0043.4003230.00%
2025/03/31044.9100.0043.0003220.00%
2025/03/28045.9800.0045.6003190.00%
2025/03/27046.0500.0045.9003190.00%
2025/03/2600.00046.7546.4503200.00%
2025/03/1900.00046.5045.3003260.00%
2025/03/17446.1500.0045.4043441.16%
2025/03/0400.000.153.4053.70-0.1302-0.02%
2025/03/03053.70054.2053.000297-0.01%
2025/02/27453.70454.7052.7002860.00%
2025/02/2600.000.150.5050.80-0.1272-0.03%
2025/02/2100.00049.8049.9002760.00%
2025/02/18449.6500.0049.3042741.46%
2025/02/1700.00050.4049.9502730.00%
2025/02/14049.4500.0049.5502710.00%
2025/02/1000.00051.0051.6002680.00%
2025/02/06050.6000.0050.9002580.00%
2025/01/1600.00150.7051.00-1226-0.44%
2025/01/102153.232.353.1351.7018.71989.41%
2025/01/080.452.6000.0051.700.41840.21%
2025/01/0700.001251.1852.10-12176-6.81%
2024/12/30049.3500.0048.8501370.00%
2024/12/200.846.9300.0046.900.81270.63%
2024/12/11148.6500.0048.6511210.82%
2024/11/29144.6000.0044.6011070.93%
2024/11/25144.60044.1044.5511080.91%
2024/11/22043.7000.0044.0001090.01%
2024/11/1900.00141.7042.15-1110-0.90%
2024/11/15241.4000.0041.9021121.78%
2024/11/05441.8500.0042.1041213.31%
2024/11/04441.8500.0042.1041263.17%
2024/10/23242.2500.0042.1021491.34%
2024/10/22442.0500.0042.4041522.63%
2024/10/2100.00142.3542.20-1158-0.63%
2024/10/18141.9000.0041.9011960.51%
2024/10/0700.00243.5043.50-2245-0.83%
2024/09/27042.5000.0042.3502980.00%
2024/09/26042.9500.0042.5003460.01%
2024/09/25143.0500.0043.2013780.26%
2024/09/20243.0300.0042.7523920.51%
2024/09/0300.00346.2046.10-3413-0.73%
2024/08/2700.00046.1546.5004320.00%
2024/08/12442.90143.5042.7534240.71%
2024/08/02142.3500.0042.3014060.25%
2024/08/0100.00743.3443.65-7403-1.73%
2024/07/31043.3500.0043.1004020.00%
2024/07/301942.6000.0043.70194024.72%
2024/07/192548.82149.6046.50243846.25%
2024/07/182147.04147.9548.00203465.78%
2024/07/1600.00144.9044.75-1328-0.30%
2024/07/11145.3000.0045.0013290.30%
2024/07/092444.8300.0044.05243297.29%
2024/07/041049.7000.0049.55102953.39%
2024/07/021051.0000.0050.40102623.82%
2024/07/0100.00449.6650.20-4214-1.86%
2024/06/2600.00046.1046.8501790.00%
2024/06/0500.00145.3044.90-1153-0.65%
2024/06/0400.00245.4044.30-2149-1.34%
2024/06/03043.5000.0042.6001370.01%
2024/05/23242.7800.0042.5021361.46%
2024/05/1000.00243.1843.40-2155-1.29%
2024/05/07142.2000.0042.4511540.65%
2024/05/06142.6500.0042.8011530.65%
2024/05/0300.00143.2542.90-1154-0.65%
2024/04/26242.4000.0042.2521551.28%
2024/04/19342.3000.0042.0531631.83%
2024/04/15244.7500.0044.5521601.25%
2024/04/12145.5000.0045.4011600.62%
2024/04/08045.3000.0045.3001650.00%
〈大江集團法說〉和康生明年營收續拚雙位數成長 淨利率維持25%Anue鉅亨-2023/11/20
和康生三大業務銷售看旺 明、後年將啟動擴產計畫Anue鉅亨-2023/07/25
和康生全年毛利率有望維持67%水準 今年將取得10張認證Anue鉅亨-2023/05/23
和康生 相關文章
 
 
55小時25